Related Experiment Video
Updated: Apr 16, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
IGFBP-rP1 suppresses epithelial-mesenchymal transition and metastasis in colorectal cancer
11] Department of Pathology, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China [2] Key Laboratory of Disease Proteomics of Zhejiang Province, Hangzhou, Zhejiang, China.
Abstract:
Epithelial-mesenchymal transition (EMT) was initially recognized during organogenesis and has recently been reported to be involved in promoting cancer invasion and metastasis. Cooperation of transforming growth factor-β (TGF-β) and other signaling pathways, such as Ras and Wnt, is essential to inducing EMT, but the molecular mechanisms remain to be fully determined. Here, we reported that insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1), a potential tumor suppressor, controls EMT in colorectal cancer progression. We revealed the inhibitory role of IGFBP-rP1 through analyses of clinical colorectal cancer samples and various EMT and metastasis models in vitro and in vivo. Moreover, we demonstrated that IGFBP-rP1 suppresses EMT and tumor metastasis by repressing TGF-β-mediated EMT through the Smad signaling cascade. These data establish that IGFBP-rP1 functions as a suppressor of EMT and metastasis in colorectal cancer.
Insights
Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) inhibits epithelial-mesenchymal transition (EMT) and metastasis in colorectal cancer. This tumor suppressor acts by blocking transforming growth factor-β (TGF-β) signaling via the Smad pathway.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Epithelial-mesenchymal transition (EMT) is crucial for cancer invasion and metastasis.
- Transforming growth factor-β (TGF-β) signaling, alongside Ras and Wnt pathways, drives EMT, but mechanisms are not fully understood.
Purpose of the Study:
- To investigate the role of insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) in colorectal cancer progression.
- To elucidate the molecular mechanisms by which IGFBP-rP1 influences EMT and metastasis.
Main Methods:
- Analysis of clinical colorectal cancer samples.
- In vitro and in vivo studies using EMT and metastasis models.
- Investigation of the Smad signaling cascade in response to IGFBP-rP1 and TGF-β.
Main Results:
- IGFBP-rP1 exhibits an inhibitory role in colorectal cancer progression.
- IGFBP-rP1 suppresses EMT and tumor metastasis.
- IGFBP-rP1 represses TGF-β-mediated EMT through the Smad signaling pathway.
Conclusions:
- IGFBP-rP1 acts as a suppressor of EMT and metastasis in colorectal cancer.
- IGFBP-rP1 represents a potential therapeutic target for inhibiting colorectal cancer spread.
Related Concept Videos
Mitogens and the Cell Cycle
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

